ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111212
Avg. Estimate-0.4-0.41-1.78-1.2
Low Estimate-0.43-0.46-1.85-1.85
High Estimate-0.36-0.33-1.730.45
Year Ago EPS-0.5-0.5-1.94-1.78
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111212
Avg. Estimate88.54M91.5M325.76M454.14M
Low Estimate86M88.07M320.87M362.06M
High Estimate91.53M95M329.77M693.18M
Year Ago Sales58.3M59.57M223.81M325.76M
Sales Growth (year/est)51.90%53.60%45.60%39.40%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.58-0.55-0.52-0.45
EPS Actual-0.5-0.5-0.59-0.38
Difference0.080.05-0.070.07
Surprise %13.80%9.10%-13.50%15.60%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.4-0.41-1.78-1.2
7 Days Ago-0.42-0.38-1.79-1.21
30 Days Ago-0.44-0.41-1.91-1.19
60 Days Ago-0.44-0.41-1.91-1.14
90 Days Ago-0.43-0.44-1.91-1.16
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/A11
Up Last 30 Days77127
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A1N/A1
Growth EstimatesACADIndustrySectorS&P 500
Current Qtr.20.00%N/AN/A-0.00
Next Qtr.18.00%N/AN/A0.08
Current Year8.20%N/AN/A0.03
Next Year32.60%N/AN/A0.10
Next 5 Years (per annum)28.10%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A